[1] |
Bi Y, Xu Y, Ning G. Prevalence of diabetes in Chinese adults-reply[J]. JAMA, 2014, 311(2): 200-201.
|
[2] |
Hotamisligil GS. Inflammation and metabolic disorders[J]. Nature, 2006, 444(7121): 860-867.
|
[3] |
Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease[J]. Nat Rev Immunol, 2011, 11(11): 738-749.
|
[4] |
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease[J]. J Clin Invest, 2011, 121(6): 2111-2117.
|
[5] |
Shu CJ, Benoist C, Mathis D. The immune systems involvement in obesity-driven type 2 diabetes[J]. Semin Immunol, 2012, 24(6): 436-442.
|
[6] |
Obrien TP, Yang GP, Sanders L, et al. Expression of cyr61, a growth factor-inducible immediate-early gene[J]. Mol Cell Biol, 1990, 10(7): 3569-3577.
|
[7] |
Lin J, Huo R, Xiao L, et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis[J]. Arthritis Rheumatol, 2014, 66(1): 49-59.
|
[8] |
Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance[J]. Science, 1993, 259(5091): 87-91.
|
[9] |
Li P, Lu M, Nguyen MT, et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice[J]. J Biol Chem, 2010, 285(20): 15333-15345.
|
[10] |
Kintscher U, Hartge M, Hess K, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance[J]. Arterioscler Thromb Vasc Biol, 2008, 28(7): 1304-1310.
|
[11] |
Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance[J]. Nat Rev Endocrinol, 2012, 8(12): 709-716.
|
[12] |
Lumeng CN, Maillard I, Saltiel AR. T-ing up inflammation in fat[J]. Nat Med, 2009, 15(8): 846-847.
|
[13] |
Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy[J]. Nat Med, 2009, 15(8): 921-929.
|
[14] |
Lau LF, Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells[J]. EMBO J, 1985, 4(12): 3145-3151.
|
[15] |
Obrien TP, Lau LF. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development[J]. Cell Growth Differ, 1992, 3(9): 645-654.
|
[16] |
Jay P, Berge-Lefranc JL, Marsollier C, et al. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p[J]. Oncogene, 1997, 14(14): 1753-1757.
|
[17] |
Leng E, Malcolm T, Tai G, et al. Organization and expression of the Cyr61 gene in normal human fibroblasts[J]. J Biomed Sci, 2002, 9(1): 59-67.
|
[18] |
王志敏, 丛雅琴, 马立宁, 等. Cyr61基因与慢性粒细胞白血病的相关性研究[J]. 山东大学学报(医学版), 2009, 47(10): 94-97. WANG Zhimin, CONG Yaqin, MA Lining, et al. Correlation between Cyr61 and chronic myelogenousleukemis[J]. Journal of Shandong University(Health Sciences), 2009, 47(10): 94-97.
|
[19] |
牛志宏, 高德轩, 丁森泰, 等. Cyr61、CTGF、NOV、WISP-1基因在肾癌中的表达[J]. 山东大学学报(医学版), 2008, 46(7): 701-703. NIU Zhihong, GAO Dexuan, DING Sentai, et al. Expression of Cyr61, CTGF, NOV and WISP-1 in renal cell carcinoma[J]. Journal of Shandong University(Health Sciences), 2008, 46(7): 701-703.
|
[20] |
Tong X, Okelly J, Xie D, et al. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway[J]. Oncogene, 2004, 23(28): 4847-4855.
|
[21] |
Matsumae H, Yoshida Y, Ono K, et al. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model[J]. Arterioscler Thromb Vasc Biol, 2008, 28(6): 1077-1083.
|
[22] |
Athanasopoulos AN, Schneider D, Keiper T, et al. Vascular endothelial growth factor(VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing[J]. J Biol Chem, 2007, 282(37): 26746-26753.
|
[23] |
Zhang Q, Wu J, Cao Q, et al. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis[J]. Arthritis Rheum, 2009, 60(12): 3602-3612.
|
[24] |
Koon HW, Shih DQ, Hing TC, et al. Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells[J]. Am J Pathol, 2011, 179(5): 2315-2326.
|
[25] |
Koon HW, Zhao D, Xu H, et al. Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis[J]. Am J Pathol, 2008, 173(2): 400-410.
|
[26] |
Lantz M, Vondrichova T, Parikh H, et al. Overexpression of immediate early genes in active Graves' ophthalmopathy[J]. J Clin Endocrinol Metab, 2005, 90(8): 4784-4791.
|
[27] |
Lin J, Zhou Z, Huo R, et al. Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis[J]. J Immunol, 2012, 188(11): 5776-5784.
|
[28] |
徐京京, 赵琳, 张晓莉, 等. 类风湿关节炎患者血清CCN1水平变化及意义[J]. 山东医药, 2016, 56(21): 58-59. XU Jingjing, ZHAO Lin, ZHANG Xiaoli, et al. Changes and significance of serum CCN1 in patients with rheumatoid arthritis[J]. Shandong Med J, 2016, 56(21): 58-59.
|
[29] |
Zhu X, Xiao L, Huo R, et al. Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis[J]. Arthritis Res Ther, 2013, 15(6): 187.
|
[30] |
Schipper HS, Prakken B, Kalkhoven E, et al. Adipose tissue-resident immune cells: key players in immunometabolism[J]. Trends Endocrinol Metab, 2012, 23(8): 407-415.
|
[31] |
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance[J]. J Clin Invest, 2006, 116(7): 1793-1801.
|